Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2017-06-01. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The firm is in the final stages of releasing the developed product for clinical studies. The firm's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción LXGTF?
El precio actual de LXGTF es de $0.0001, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Lexington Biosciences Holdings Corp?
Lexington Biosciences Holdings Corp pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Lexington Biosciences Holdings Corp?
La capitalización bursátil actual de Lexington Biosciences Holdings Corp es $378.684
